Clinical Trials >> Head and Neck >> TITAN >> Endpoints

Trial Endpoints

This is currently a feasibility study with an intention to progress to phase III if feasibility is demonstrated.


Primary Outcome

The primary endpoint is the feasibility of recruitment into the TITAN trial (specifically the number of patients recruited from at least 4 centres during a 12 month period).


Secondary outcomes

  • Randomisation: Screening ratio.
  • The percentage of patients in the TPF arm who complete the full course of treatment (including post-operative radiotherapy/chemoradiotherapy).


Admin/Site Area

Username:
Password:
Forgotten Password


"The experience and treatment I received at the Royal Liverpool Hospital was so fantastic that I had to tell the people involved with my treatment how marvelous they were, so please would you pass on my thanks and gratitude to Professor Neoptolemos and his team of surgeons, the wonderful doctors and nursing staff" - Anon (Participant in ESPAC-3(v2) trial)

Read more Patient stories